![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 45, 43425-43432, November 8, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
¶,
§,
,
**, and

From the
Département d'Ingénierie et
d'Etudes des Protéines, CEA-Saclay, 91191 Gif sur Yvette
cedex and the
Biophysique Moléculaire et
Cellulaire, Unité Mixte de Recherche 5090, Département
Réponse et Dynamique Cellulaires, Commissariat à l'Energie
Atomique-Grenoble, 17 rue des Martyrs, 38054 Grenoble, cedex 9, France
Received for publication, April 29, 2002, and in revised form, July 30, 2002
| |
ABSTRACT |
|---|
|
|
|---|
The study of the membrane insertion of the
translocation domain of diphtheria toxin deepens our insight into the
interactions between proteins and membranes. During cell intoxication,
this domain undergoes a change from a soluble and folded state at
alkaline pH to a functional membrane-inserted state at acid pH. We
found that hydrophobic and electrostatic interactions occur in a
sequential manner between the domain and the membrane during the
insertion. The first step involves hydrophobic interactions by the
C-terminal region. This is because of the pH-induced formation of a
molten globule specialized for binding to the membrane. Accumulation of
this molten globule follows a precise molecular mechanism adapted to
the toxin function. The second step, as the pH decreases, leads to the
functional inserted state. It arises from the changes in the balance of
electrostatic attractions and repulsions between the N-terminal part
and the membrane. Our study shows how the structural changes and the
interaction with membranes of the translocation domain are finely tuned
by pH changes to take advantage of the cellular uptake system.
Folding and insertion of membrane proteins (1, 2), binding of
hormones to membrane receptors (3), action of antibiotic peptides (4,
5), protein translocation, and internalization of toxins (6) are
examples of phenomena that require the interactions of polypeptide
chains with membranes. Because of the anisotropic nature of membranes,
the initial steps of the association and the final structure and
localization of polypeptide chains within membranes depend on a
combination of hydrophobic and electrostatic interactions (7).
Hydrophobic interactions are dominant for the insertion of
transmembrane polypeptides. Electrostatic interactions are important
for the binding of antibiotic peptides (5, 8), the association of
proteins with the surface of the membrane (9-11), and as determinants
of the topology of integral membrane proteins after biosynthesis (12).
In most cases, electrostatic interactions are the result of the
attraction between anionic phospholipid head groups and basic amino
acid side chains (13, 14). However, there are examples where
electrostatic repulsions are involved in the membrane association of
peptides, particularly when their structure and localization within the
membrane is regulated by the pH (15-19). The interplay of
hydrophobicity and electrostatics and their distribution within the
polypeptide sequence have only been studied in detail for small
peptides (3-5, 7, 13-15, 17-20). In the case of proteins, the role
of these effects on the association with and the insertion into
membranes are still poorly understood (2, 21-24).
The study of the membrane insertion process of the translocation
(T)1 domain of diphtheria
toxin (25) can provide precious insight into the interactions between
proteins and membranes and the refolding mechanisms of membrane
proteins. During intoxication of cells (25), the toxin reaches the
early endosomes through the clathrin-coated pathway (26). Because of
the acid pH found in this compartment, the T domain changes from a
soluble state with a stable tertiary structure to a functional
membrane-inserted state (27-34) and helps the catalytic domain to
reach the cytosol. In its soluble form (Fig.
1), the T domain (22 kDa) is structured
in a bundle of nine
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-helices organized in three layers (35, 36). A
central hydrophobic helical hairpin made of helices TH8 and TH9 is
hidden from the solvent by two amphiphilic layers made of the TH1-TH4
and TH5-TH7 groups of
-helices. Such topology is found for other
membrane-penetrating proteins such as the pore-forming domain of
colicins (37) and the pro- or anti-apoptotic proteins belonging to the
Bcl-2 family (38). The N-terminal region (TH1-TH4) contains many
negative and positive residues at neutral pH.

View larger version (44K):
[in a new window]
Fig. 1.
Structure of the T domain using
the Molmol program (66). Helices TH1 to TH9 are shown
organized in three layers, a central hydrophobic helical hairpin
(TH8-TH9 in blue) hidden from the solvent by two amphiphilic
layers (TH1-TH4 in red, and TH5-TH7 in green).
Side chains of Trp-206 and Trp-281 are shown in
yellow.
We have found that first hydrophobic, and then electrostatic,
interactions are involved during the insertion of the T domain in a
membrane. On the basis of our results we propose a model that describes
how these two kinds of interactions are controlled by pH and involve
distinct regions of the domain. In a first step, hydrophobic
interactions by the C-terminal TH8-TH9 helices are allowed by the
pH-induced partial unfolding of the soluble form. In a second step,
further acidification changes the balance of electrostatic attractions
and repulsions between the N-terminal part of the domain and the
membrane surface, leading to increased penetration into the membrane.
Our study shows how the structural changes and the interaction with
membranes of the T domain are finely tuned by pH changes to take
advantage of the cellular uptake system.
| |
EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
Recombinant Proteins-- The recombinant T domain has been described previously (39, 40). Cys-201 (native diphtheria toxin numbering) has been mutated to Ser. The protein was further purified on a 1-ml anion exchange column (HiTrapTM Q-SepharoseTM HP; Amersham Biosciences).
Lipid Vesicles-- Anionic lipid vesicles were prepared in 10 mM sodium citrate buffer (pH 7.8) from egg phosphatidyl choline (EPC) and egg phosphatidic acid (EPA) (Avanti Polar Lipids, Alabaster, AL) at a 9:1 molar ratio by reverse phase evaporation (41, 42) to obtain large unilamellar vesicles (LUV) or by sonication to obtain small unilamellar vesicles (SUV).
Experimental Buffers-- The protein was kept in 20 mM phosphate buffer and was diluted in a range of 5 mM citrate buffers of various pH before spectroscopic measurements. The pH of the diluted protein was checked afterward. All experiments were done at 22 °C.
CD Spectropolarimetry--
CD experiments were performed on a
CD6 spectrodichrograph (Jobin-Yvon Instruments, Longjumeau, France) as
described previously (40). The scans were recorded using a bandwidth of
2 nm and an integration time of 1 s at a scan rate of 0.5 nm·s
1. The spectra were corrected for the blank, and a
smoothing algorithm was then used with the minimum filter in the CD6
software (CDMax, filter 5).
Fluorescence Spectroscopy--
Fluorescence measurements were
performed with an FP-750 spectrofluorimeter (Jasco, Tokyo, Japan) in a
thermostated cell holder, using a 1-cm path length quartz cell as
described previously (40). A bandwidth of 5 nm was used for both
excitation and emission beams. The excitation wavelength was fixed at
295 nm where the contribution of Tyr is negligible. The emission
spectra were recorded from 300 to 500 nm at a scan rate of 60 nm·min
1. Maximal emission wavelength
(
max) represents the average of five values obtained
from emission spectra that were corrected for blank measurements.
Binding Curves--
The various pH dependence monitored in this
study were fitted with the following binding curve equation:
S = Si + (Sf
Si)/(1 + (K/H)nH), where
S is the signal used to monitor the reaction,
Si and Sf are the initial
and final values, respectively, H is the proton concentration, H = 10
pH, K is
the dissociation constant, and nH is the Hill
coefficient. When intrinsic fluorescence was used, we chose to show
max as a function of pH, because it provides direct
information about the Trp environment. Unlike the fluorescence
intensity at a fixed wavelength,
max is not an extensive
variable. To be exact one should not use
max to be
fitted by a binding curve. In the case of intrinsic fluorescence of
proteins, however, it can provide reliable thermodynamic parameters of
a reaction (43). This is confirmed by our study where the pH dependence
of
max was systematically compared with a different kind
of data (CD, partition, or fluorescence resonance energy
transfer (FRET)). In addition, we used the binding curve fitting to the
pH dependence of
max in the presence of membranes to
estimate the value of
max after the first step of the
conformational change, to gather information about the Trp environment
at that stage.
Integrated Stopped-flow Fluorescence Kinetics-- Fast fluorescence time courses were recorded with an SFM-3 stopped-flow (Bio-Logic, Claix, France) equipped with a 15-µl observation chamber. The excitation wavelength was 299 nm (2-nm bandwidth), and the emitted light was detected through a cut-on filter excluding light below 330 nm. About 10 traces were accumulated for each experiment, and the average trace was fitted with the BioKine program (Bio-Logic, Claix, France).
Liposome Permeabilization Assay-- Experiments were performed as described previously (42).
FRET-- Dansyl-DHPE (D-57; Molecular Probes) was mixed with methanol and dissolved by sonication to give a 12.18 mM stock solution. SUV containing dansyl were prepared from dansyl-DHPE, EPC, and EPA at a 5:90:10 molar ratio. For each pH, aliquots of T were added, and FRET was measured (Excitation wavelength: 292 nm; emission wavelength: 520 nm) until fluorescence intensity reached a plateau. Fluorescence intensity of the dansyl at the plateau was normalized to its initial fluorescence in the absence of T.
Binding of T to LUV Studied by Centrifugation--
A 5.23 mM stock solution of NBD-PE (N-360; Molecular
Probes) was prepared in chloroform. LUV were prepared from EPC, EPA, and NBD-PE at a 90:10:0.3 molar ratio. Vesicles and proteins were incubated in 8 ml for 2 h. After fluorescence measurements, 4 ml
of each sample were neutralized and centrifuged 2 h later. The
other 4 ml were directly centrifuged in a Beckman L-70 ultracentrifuge using a Ti 70.1 rotor at 4 °C for 1.5 h at 70,000 rpm
(350,000 × g). Pelleting efficiency was determined by
comparison of the NBD-PE fluorescence (Excitation wavelength: 292 nm;
emission wavelength: 520 nm) in the supernatant with that measured
before centrifugation. The partitioning of T was determined as follows:
p = (Fo
F)/Fo, where
Fo and F are the fluorescence
intensities of T before and after centrifugation, respectively. LUV
were used instead of SUV, because they gave better pelleting.
| |
RESULTS |
|---|
|
|
|---|
Mechanisms of the pH-induced Conformational Change of the T
Domain--
The far-UV CD spectrum of the T domain (Fig.
2A) indicates a substantial
-helix content, consistent with the structure deduced from x-ray
crystallography (35, 36). The amount of secondary structure does not
depend on pH (Fig. 2A). The near-UV CD spectrum of T at
neutral pH, i.e. in the S-state, displays a large signal at
292 nm, which vanishes at acid pH (Fig. 2B). This signal can be attributed to Trps stabilized in a rigid chiral environment, and it
reveals their embedding in tertiary structure at neutral pH (44).
Therefore, CD spectra show that at acid pH, i.e. in the
A-state, the tertiary structure is lost whereas the secondary structure
remains native-like. 1-Anilinonaphthalene-8-sulfonic acid (ANS)
binding experiments (data not shown) also indicate that hydrophobic
surfaces become exposed to solvent, in agreement with earlier work (28,
45). Moreover, the one-dimensional NMR spectrum of T at acidic
pH shows a drastic diminution of the chemical shift dispersion,
together with broader peaks, as compared with the spectrum in the
native state (data not shown). Such an NMR spectrum indicates that
important conformational exchanges occur in the A-state on the
millisecond time scale (46-48). Overall, the structural
characteristics of the A-state are those commonly accepted for the
molten globule state, which is observed in the folding reaction of many
proteins (49).
|
The conformational change induced by acid pH is fully reversible,
because the peak at 292 nm detected by CD in the near-UV at neutral pH
and lost at acid pH is recovered after neutralization of the acid
sample (Fig. 2B). It is not possible to monitor the tertiary
structure of T as a function of pH by near-UV CD because of aggregation
of T around pH 5.5 at the protein concentrations needed for CD
experiments (40). However, this is possible by recording
max of the Trps (Fig. 3).
Aggregation is avoided, because lower protein concentrations are used
for the fluorescence experiments. As the tertiary structure is
destabilized, the Trp environment becomes more polar as shown by the
red shift in
max from 336 nm in the S-state to 342 nm in
the A-state (Fig. 3), in agreement with previous studies (30). This
change in the fluorescence spectrum occurs between pH 6 and 5 and is
fully reversible regardless of the pH values investigated (Fig. 3).
|
The pH dependence of the equilibrium between the S- and A-states can be described with a dissociation constant, pKEq = 5.5, and a Hill coefficient, nH = 2.8 (Fig. 3), a value that indicates that at least three protons participate in a cooperative manner in the conformational change. For comparison, similar binding parameters were extracted from the near-UV CD changes of a fusion protein, ZZ-T (data from Ref. 40), in which the structural and functional behaviors of T are preserved and that is soluble at the high concentrations needed for CD regardless of the pH.
To gain more insight into the role of protons in the stabilization of
the A-state, the kinetics of the transition from the S- to the A-state
were monitored for various final pH values by recording the
fluorescence change due to the conformational change. As in both
steady-state and kinetics experiments the same phenomenon is monitored
by using intrinsic fluorescence, it is possible to draw some
conclusions regarding the mechanism of the pH-induced conformational
change from the comparison of the two pH dependences. The kinetics of
the fluorescence change were fitted with a single exponential decay.
The observed rate constant (kobs) strongly increases from 0.7 s
1 at pH 4.85 to 44.4 s
1
at pH 2.8 (Fig. 4) and seems to reach a
plateau for pH values lower than 3 (Fig. 4, inset). It is
difficult to obtain experimental kobs values for
pH values lower than 2.8, because T becomes unstable. When the
experiment is conducted in the reverse direction, i.e. starting from T prepared at pH 4.6 and then mixed with a buffer to
reach a final pH of 7.8, the reaction is slower with
kobs = 0.14 s
1. The pH dependence
of the rate constant indicates that a binding of protons is associated
with the rate-limiting step of the conformational change (50-53). A
simple way to describe the pH dependence of kobs is to consider that the proton binding is a fast event that precedes the conformational change. In that case kobs is
controlled by this event and depends on the proportion of the
protonated species. The final conditions used for the kinetic
measurements are highly favorable to the A-state. Indeed, in these
experiments the final pH is lower than 4.8, and according to the
equilibrium experiments (Fig. 3), a large majority of the protein is in
the A-state under these conditions. Therefore, as an approximation, we
can consider the reaction as a one-way reaction. Then, the pH
dependence of kobs can be written in terms of
binding constants as follows: kobs = k0/(1 + 10 (
nH(pKKi
pH))), where k0 is the rate of the
conformational change of the protonated S-state, pKKi is the dissociation constant of the
proton binding to the S-state, and nH reflects
the cooperativity of the binding. The pH dependence of
kobs can be described with the following parameters: pKKi = 3.6, nH = 1.4, and k0 = 48 s
1 (±1 s
1) (Fig. 4). The pK and
the cooperativity of the proton binding associated with the
rate-limiting step of the conformational change are lower than those
obtained at equilibrium, pKEq = 5.5, and nH = 2.8. Thus, an additional binding of protons
must occur after the rate-limiting step monitored in the kinetics. This
additional binding must be of high affinity to increase the apparent
pK and nH of the transition at
equilibrium in contrast to those of the binding that control the rate
of the conformational change. According to the two different
nH values obtained from kinetic and steady-state experiments, the binding of at least two protons is associated with the
rate-limiting step of the conformational change
(nH = 1.4), whereas at least three protons are
involved in the whole conformational change (nH = 2.8). For the sake of simplicity in the model proposed below to
interpret our results, we show the binding of only two and one-third
protons for each step, respectively. Scheme
1 is the minimal scheme to
describe both the steady-state and kinetic experiments.
|
|
The sequential binding of two protons to the S-state accounts for the
cooperative binding that controls the rate of the conformational change
(S- to A-state). K1a and
K1b can be calculated from the parameters of the
pH dependence of kobs as follows:
K1a = KKi/(4/nH
2)
and K1b = KKi × (4/nH
2) (54). The values we obtain with
pKKi = 3.6 and nH = 1.4 are pK1a = 3.55 and
pK1b = 3.7. These two initial protonations induce a conformational change that, in turn, exposes to the solvent at
least one additional amino acid, now open to protonation. The binding
of the third proton determines the dissociation constant and the
nH observed in the steady-state experiment.
S, SH, and SH2 (the S-state with various amount of
bound protons in Scheme 1) have the same fluorescence characteristics,
i.e.
m = 336 nm. SH2
spontaneously changes its conformation in AH2 (the A-state with two bound protons), and this rate-limiting equilibrium
(K2 = SH2/AH2 = kalkaline/kacid) favors
the AH2 species, which could be stabilized by a further
protonation in AH3. Within AH2 and AH3, the Trps are more exposed to solvent, i.e.
m = 342 nm. In the rate-limiting equilibrium,
kacid is determined from the pH dependence of
kobs, kacid = k0 = 48 s
1. The rate of the
conformational change induced by a pH jump from 4.6 to 7.8, which is
highly favorable to the S-state, can be used as an approximation for
kalkaline, kalkaline
0.14 s
1. Then, K2 can be
estimated, pK2
2.5, and
K3 can be calculated from these values and the
parameters of the steady-state experiments (pKEq = 5.5), pK3
6.75 (K3
KEq3/K1aK1bK2,
the other terms of the relationship being negligible). One can notice
here that such calculations can be helpful for the identification of
the amino acids responsible for the sensitivity to the pH of the
conformational change. The values of pK1a and pK1b (3.55 and 3.7, respectively) suggest that
the protonations of aspartates (pKa3 = 3.9) or glutamates (pKa3 = 4.3) are
responsible for the first step, whereas histidines (pKa3 = 6) could be involved in the
second step (pK3
6.75).
Interactions of the T Domain with Membranes--
The two Trps of
the T domain are located in the TH1 and TH5 helices. When Trp
fluorescence is used to monitor the pH-induced conformational changes
of the T domain in the presence of anionic SUV made of a mixture of
neutral and negative phospholipids (EPC and EPA 9/1, respectively), two
steps are detected (Fig. 5A). The first step occurs between pH 7 and pH 6. The shift of
max from 336 to 344 nm indicates that the Trps become
more accessible to the solvent. During the second step, between pH 6 and pH 4, the
max moves from 344 nm at pH 6 to 333 nm at
pH 4. This shows that the Trps penetrate a hydrophobic environment. A
similar pattern for the pH dependence of
max is obtained
when the experiment is performed with LUV instead of SUV (data not
shown). After the first step, the secondary structure of the T domain
is preserved. Indeed, the far-UV CD spectra recorded in the presence of
anionic SUV at pH 6 and pH 7 are identical (Fig.
6A). During the second step,
however, a small increase of the helicity (Fig. 6B) and the
burying of the Trps in a hydrophobic environment (Fig. 5A) are concomitant.
|
|
The two steps can be monitored separately either by measuring the
partition between the membrane-bound domain and the free domain or by
measuring the FRET between dansyl (a fluorescent probe linked to
phospholipid head groups) and Trps (Fig. 5B). Partition
measurements indicate that the domain binds to the membrane during the
first step (between pH 7 and pH 6). The establishment of the FRET
between the dansyl and Trps occurs in the second step. No conclusion
can be drawn from the FRET data about the location of the Trps within
the membrane. The distance between Trps and dansyl molecules is not the
only factor that determines the level of FRET. It also depends on the
max and the intensity of the Trp fluorescence, two
factors which vary. The second step is also related to a
permeabilization of the membrane (between pH 6 and pH 4). Indeed, a
fluorescent probe, trapped previously in the liposomes, is released and
quenched for pH values lower than 6 (Fig. 5C). The
permeabilization appears in the same range of pH when SUV or LUV are used.
Both transitions are determined by the binding of protons. The best fit
of a binding curve to the partition data gives pK = 6.6 and nH = 3.3 (Fig. 5B). The high
cooperativity of the first transition suggests that the formation of
the A-state, described previously in the absence of membrane, is a
prerequisite for binding to the membrane. The pH dependence of the
first step is shifted toward more alkaline pH values in the presence of
membranes as compared with the pH dependence of the formation of the
A-state in the absence of membrane. This could be explained by the
interaction with the membrane, which stabilizes the partially folded
state. The best fit to the FRET data, which is related to the second step of the interaction, gives pK = 5.7 and
nH = 1.3. To estimate
max after
the first step, the pH dependence of
max is fitted for
each of the two parts of the binding curve in Fig. 5A. The parameters of proton binding for the first step are pK = 6.4 and nH = 2.7, and those for the second
step are pK = 5.75 and nH = 1.1. These values of the binding parameters are similar to those obtained
from the partition and FRET data. This fit provides an estimation of
max after the first transition of 350 nm. It shows that,
after the first step, the environment of the Trps is more polar than in
the A-state in solution (
max = 342 nm).
When neutral membranes made of zwitterionic phospholipids (EPC only)
are used, binding to the membrane and partial unfolding are detected,
but the second step associated with the burying of the Trps in a
hydrophobic environment (Fig. 5A) is not. The best fit to a
binding curve gives pK = 7.0 and
nH = 1.9. The
max of the Trp
fluorescence after binding is around 342 nm, similar to that found for
the A-state. Therefore, after the initial binding, the environment of
the Trps is less polar with neutral membranes as compared with anionic
ones (
max = 350 nm). In the presence of neutral
membranes, the second step does not occur (Fig. 5A). In this
case, a weak permeabilization of the membrane can be detected only for
small values of L/P (L/P = 75) but not when values of L/P are
similar to those leading to permeabilization with anionic membranes,
i.e. L/P = 3000 (Fig. 5C). These results
show that electrostatic interactions between the T domain and acid
phospholipids are essential for the second step, i.e. the
membrane permeabilization. As a confirmation, the addition of 0.1 M NaCl inhibits partially the second transition observed in
the presence of anionic membranes, whereas the first step remains
unchanged (Fig. 7). One can notice that
in this experiment the pH dependence is slightly shifted by comparison
with the previous one (Fig. 5A). This is probably because of
the use of a different batch of phospholipids for this last experiment.
All of the previous experiments were made with the same batch of
phospholipids but various preparations of T domain.
|
| |
DISCUSSION |
|---|
|
|
|---|
The formation at acid pH of the A-state of the T domain that is able to interact with membranes depends on the cooperative binding of at least three protons. The binding of at least two protons to the S-state is a prerequisite to the conformational change leading to the A-state. The pKs of these two protons suggest that either glutamates or aspartates are involved. In solution, the binding of at least a third proton (probably on a histidine) stabilizes the A-state. Then, two steps can be distinguished in the interaction between the T domain and a membrane, first a binding step and then a structural reorganization associated with a permeabilization of the membrane.
The high cooperativity of the pH dependence of the first step of the
interaction suggests that the binding of the T domain to the membrane
is controlled by the formation of the A-state. In this state, the
hydrophobic regions of the protein are more accessible to the solvent.
Most likely, the hydrophobic TH8 and TH9
-helix hairpin becomes
available for insertion in the membrane, as it was shown to penetrate
the bilayer (27, 29, 32). Once bound to the membrane, the structure of
the domain depends on the charge of the membrane surface. After the
first step of the interaction (around pH 6) (Fig. 5A), Trps
are in a more polar environment when the membrane is negatively charged
than when the membrane is neutral. In addition, on neutral membranes
the interaction cannot proceed to the second step observed at pH < 6 on negative membranes. Both Trps being located in the N-terminal part of the domain (on TH1 and TH5), this difference is probably because of electrostatic interactions between anionic phospholipids and
charged residues also located in this region. The
-helices of T are
preserved (Fig. 6). This suggests that the
-helices of the
N-terminal part of the T domain are lying on the membrane surface.
Furthermore, in the absence of interaction with other
-helices, it
is likely that the TH8 and TH9 hydrophobic
-helix hairpin is
inserted in the hydrophobic core of the membrane (27, 29, 32).
Likewise, in the presence of neutral membranes, without the possibility
of electrostatic interactions between the membrane surface and the
N-terminal part of the domain, TH8 and TH9 are likely to be responsible
for the binding through hydrophobic interactions. In this case the
conformational change due to the interaction with the membrane
occurs for higher pH values than previously, and the
apparent cooperativity of the binding is lower (Fig. 5A). Probably, states other than AH3 are also able to bind to
neutral membranes. This suggests that, in the case of anionic
membranes, electrostatic repulsions between anionic phospholipids and
some of the acid residues that are protonated during the transition from the S- to the A-state, are involved in the pH regulation of the
binding to the membrane. Acid residues located in the loop linking TH8
to TH9 are good candidates for this regulation. There is much evidence
indicating that residues Glu-349 and Asp-352 are responsible for
the pH dependence of the insertion of TH8 and TH9 in the membrane
(55-57). Nevertheless, it has been reported that other residues may
also contribute to the pH-dependent membrane insertion of
TH8-TH9 (34).
The need for electrostatic interactions suggests that the highly charged N terminus of the T domain, TH1-TH4, plays a key role in the second step of the interaction, which is related to the permeabilization of the membrane. The need for electrostatic interactions and the pH dependence of the second step are difficult to explain if we assume that the N-terminal part of the domain adopts a stable transmembrane conformation. Likely, TH1-TH4 remains lying on the membrane surface with basic residues in interaction with anionic phospholipids. The behavior of the T domain during the membrane permeabilization shows some similarities with that of antibiotic (4, 58) and toxin peptides (59). They are made of an amphiphilic helix that binds to anionic phospholipids. These peptides form transient pores made of a peptide-lipid supramolecular complex, and upon membrane permeabilization a fraction of the peptide is translocated (20, 58). Electrostatic interactions between anionic phospholipids and basic residues are of prime importance in this phenomenon (20). One can imagine such behavior for the N-terminal part of the T domain. It would explain the membrane permeabilization and the central role played by electrostatic interactions in this activity. Moreover, structural studies have shown that the TH1-TH4 region is translocated in relation to channel formation (33), as described for peptides (20, 58). The weak permeabilization of neutral membranes can be attributed to residual binding of the N-terminal part to the membrane surface. A similar behavior has been described for peptides forming transient pores (59). The membrane permeabilization becomes weaker, and the lipid/protein ratio needed decreases when the amount of acid phospholipids in the membrane decreases (59), in a similar way as we observed for the T domain in the presence of neutral membranes.
The pH dependence of the interaction of the N-terminal part of the
domain with the membrane can be illustrated with the
-helix TH1
(Fig. 8). Its structure is quite peculiar
with a hydrophobic face separated from a negatively charged one by two
positively charged bands (27). After binding to the membrane around pH 6, it is likely that both basic and acid residues carry electric charges. Therefore, the electrostatic interactions are a combination of
attractions and repulsions between residues and anionic phospholipid head groups. As a consequence, the N-terminal part of the domain lies
on the membrane surface within the interface area (Fig. 8). At this
stage of the membrane interaction, the repulsive component is strong
enough to keep the hydrophobic face of TH1, where one of the Trps is
located, and the hydrophobic face of TH5, which contains the second
Trp, away form the hydrophobic core of the membrane. Within the pH
range of the second transition, the acid phospholipids (EPA) are still
negatively charged (pKa = 2.9), and the basic
residues remain positively charged, whereas the acid residues may loose
their negative charge by protonation of their side chain. Considering
that the local pH within the anionic membrane interface can be more
acid than the bulk pH by up to two orders of magnitude (60, 61), the
apparent pK = 5.7 for the second step is in agreement
with the protonation of acid residues (pK ~3.9-4.2).
After the electrostatic repulsion has vanished, the interaction between
the N-terminal part and the membrane depends on the electrostatic
attraction and hydrophobic interaction. As a consequence, the
localization of the N-terminal part within the membrane interface
changes. The hydrophobic regions can contact the hydrophobic core of
the membrane. The basic side chains can interact with anionic lipids.
In the case of TH1, the positively charged bands running along this
helix should be in tight interaction with anionic phospholipid head
groups. At the same time, the hydrophobic face, where one of the Trps
is located, should be in contact with the hydrophobic phase of the
membrane (Fig. 8), as shown by the blue shift of
max
(Fig. 5A). Similar changes in the position of a helix at the
membrane interface, with changes in the balance between electrostatic
and hydrophobic interactions, have already been described for peptides
(14, 17). At this stage, the N-terminal part could be translocated to
equilibrate its distribution on both sides of the membrane.
On the basis of the observations made on antibiotic and toxin peptides
(20, 58), we propose that membrane permeabilization results from this
translocation. This can be related to the function of the T domain
within the diphtheria toxin, which is to translocate the catalytic
domain, bound to the N terminus of TH1 by a disulphide bridge (25). The
translocation of the TH1-TH4 part is probably necessary for the
translocation of the catalytic domain (62).
|
The translocation of the catalytic domain is sensitive to a
transmembrane pH gradient between the endosome and the cytosol (63,
64). One can predict the effect of such transmembrane pH gradient with
a simple model, which takes into account a pH-dependent translocation of the TH1-TH4 part of the T domain. Scheme
2 describes this model.
|
KH is the dissociation constant of the
protonation of acid side chains. For the sake of simplicity we assume
that KH is the same on both sides of the
membrane, KH = Tc × Hc/TcH = Tt × Ht/TtH, Hc and Ht are the
proton concentrations on the cis- and trans-sides, respectively.
KMb is the equilibrium constant for the
distribution of the N terminus on the cis (Tc)
and trans (Tt) sides of the membrane. We assume
that, when protonated, the N terminus is equally distributed between
the two faces of the membrane, KMb = TtH/TcH = 1. Inside the endosome, when the catalytic domain is translocated, the pH is ~5.5-6 (65). With this value for the pH on the cis-side we
can calculate the proportion of N terminus on the cytosolic side as a
function of the pH on that side of the membrane, i.e. the
trans-side (Fig. 9). Thus, in
the absence of a pH gradient, the TH1-TH4 part is equally
distributed on both sides of the membrane. However, in the presence of
a pH gradient, the TH1-TH4 part remains trapped on the alkaline
side of the membrane, because acid side chains are negatively charged.
When the pH on the trans-side is equal to the pH generally found in the
cytosol (pH 7.2), a large majority of the N terminus of the T domain
would be on the trans-side (Fig. 9). Thus, the yield of translocation
of the catalytic domain, together with the N terminus part of the T
domain, is enhanced with a pH gradient. The predictions based on our
model are in agreement with measurements made on purified endosomes
(64). With a cis pH of 5.3, the largest effect of a transmembrane pH gradient on the translocation yield is observed when the trans pH is
between 6 and 7.
|
Our study provides a new insight into the mechanism by
which the pH, the composition of the membrane, and a transmembrane pH
gradient can regulate the activity of the diphtheria toxin T domain.
This allows the toxin to take advantage of the cellular uptake system
with high efficiency and specificity. The set of experiments and data
presented herein will be used as a basis for further characterization
of the interplay between the various interactions involved in
protein-membrane association and particularly to unveil how the primary
sequence codes for the interaction of proteins with membranes.
| |
ACKNOWLEDGEMENTS |
|---|
We thank A. Urvoas for help with the spectrofluorimeter and E. Mintz and Y. Gaudin for careful reading of the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported in part by the Commissariat à l'Energie Atomique, the CNRS, the Ligue Nationale Contre le Cancer, and Association pour la Recherche Contre le Cancer Grant 5876.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Supported by the Ministère de l'Education Nationale, de la Recherche et de la Technologie.
¶ Supported by the Commissariat à l'Energie Atomique.
** To whom correspondence may be addressed. Tel.: 33-1-69-08-76-46; Fax: 33-1-69-08-94-30; E-mail: daniel.gillet@cea.fr.

To whom correspondence may be addressed. Tel.:
33-4-38-78-94-05; Fax: 33-4-38-78-54-87; E-mail:
forge@dsvsud.cea.fr.
Published, JBC Papers in Press, August 21, 2002, DOI 10.1074/jbc.M204148200
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
T, translocation;
EPA, egg phosphatidic acid;
EPC, egg phosphatidyl
choline;
FRET, fluorescence resonance energy transfer;
max, maximum emission wavelength;
L/P, lipid/protein;
LUV, large unilamellar vesicles;
SUV, small unilamellar vesicles;
NBD-PE, N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine,
triethylammonium salt;
Dansyl-DHPE, N-(5-dimethylaminonaphthalene-1-sulfonyl)-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine,
triethylammonium salt.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Booth, P. J., and Curran, A. R. (1999) Curr. Opin. Struct. Biol. 9, 115-121[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Watts, A. (1995) Biochem. Soc. Trans. 23, 959-965[Medline] [Order article via Infotrieve] |
| 3. | Backlund, B. M., Wikander, G., Peeters, T. L., and Graslund, A. (1994) Biochim. Biophys. Acta 1190, 337-344[Medline] [Order article via Infotrieve] |
| 4. | Matsuzaki, K., Murase, O., Fujii, N., and Miyajima, K. (1995) Biochemistry 34, 6521-6526[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
Zhang, L.,
Rozek, A.,
and Hancock, R. E.
(2001)
J. Biol. Chem.
276,
35714-35722 |
| 6. | Lesieur, C., Vecsey-Semjen, B., Abrami, L., Fivaz, M., and Gisou van der Goot, F. (1997) Mol. Membr. Biol. 14, 45-64[Medline] [Order article via Infotrieve] |
| 7. | White, S. H., and Wimley, W. C. (1994) Curr. Opin. Struct. Biol. 4, 79-86 |
| 8. | Matsuzaki, K., Sugishita, K., Fujii, N., and Miyajima, K. (1995) Biochemistry 34, 3423-3429[CrossRef][Medline] [Order article via Infotrieve] |
| 9. |
Mosior, M.,
and Newton, A. C.
(1995)
J. Biol. Chem.
270,
25526-25533 |
| 10. |
Smith, E. R.,
and Storch, J.
(1999)
J. Biol. Chem.
274,
35325-35330 |
| 11. | Stahelin, R. V., and Cho, W. (2001) Biochemistry 40, 4672-4678[CrossRef][Medline] [Order article via Infotrieve] |
| 12. | Nilsson, I., and von Heijne, G. (1990) Cell 62, 1135-1141[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Kim, J.,
Mosior, M.,
Chung, L. A., Wu, H.,
and McLaughlin, S.
(1991)
Biophys. J.
60,
135-148 |
| 14. | Liu, L. P., and Deber, C. M. (1997) Biochemistry 36, 5476-5482[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Dathe, M., Schumann, M., Wieprecht, T., Winkler, A., Beyermann, M., Krause, E., Matsuzaki, K., Murase, O., and Bienert, M. (1996) Biochemistry 35, 12612-12622[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Arbuzova, A., Schmitz, A. A., and Vergeres, G. (2002) Biochem. J. 362, 1-12[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Leenhouts, J. M., van den Wijngaard, P. W., de Kroon, A. I., and de Kruijff, B. (1995) FEBS Lett. 370, 189-192[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Hunt, J. F., Rath, P., Rothschild, K. J., and Engelman, D. M. (1997) Biochemistry 36, 15177-15192[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Han, X., Bushweller, J. H., Cafiso, D. S., and Tamm, L. K. (2001) Nat. Struct. Biol. 8, 715-720[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Matsuzaki, K., Nakamura, A., Murase, O., Sugishita, K., Fujii, N., and Miyajima, K. (1997) Biochemistry 36, 2104-2111[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Heymann, J. B., Zakharov, S. D., Zhang, Y. L., and Cramer, W. A. (1996) Biochemistry 35, 2717-2725[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Mindell, J. A.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
4081-4083 |
| 23. | Rankin, S. E., Watts, A., and Pinheiro, T. J. (1998) Biochemistry 37, 12588-12595[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | Ladokhin, A. S., and White, S. H. (2001) J. Mol. Biol. 309, 543-552[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Chenal, A., Nizard, P., and Gillet, D. (2002) J. Toxicol. Toxin Rev. 21, 321-359 |
| 26. | Lemichez, E., Bomsel, M., Devilliers, G., vanderSpek, J., Murphy, J. R., Lukianov, E. V., Olsnes, S., and Boquet, P. (1997) Mol. Microbiol. 23, 445-457[Medline] [Order article via Infotrieve] |
| 27. |
D'Silva, P. R.,
and Lala, A. K.
(2000)
J. Biol. Chem.
275,
11771-11777 |
| 28. | Zhan, H., Choe, S., Huynh, P. D., Finkelstein, A., Eisenberg, D., and Collier, R. J. (1994) Biochemistry 33, 11254-11263[CrossRef][Medline] [Order article via Infotrieve] |
| 29. |
Kachel, K.,
Ren, J.,
Collier, R. J.,
and London, E.
(1998)
J. Biol. Chem.
273,
22950-22956 |
| 30. | Malenbaum, S. E., Collier, R. J., and London, E. (1998) Biochemistry 37, 17915-17922[CrossRef][Medline] [Order article via Infotrieve] |
| 31. |
Senzel, L.,
Huynh, P. D.,
Jakes, K. S.,
Collier, R. J.,
and Finkelstein, A.
(1998)
J. Gen. Physiol.
112,
317-324 |
| 32. | Oh, K. J., Zhan, H., Cui, C., Altenbach, C., Hubbell, W. L., and Collier, R. J. (1999) Biochemistry 38, 10336-10343[CrossRef][Medline] [Order article via Infotrieve] |
| 33. |
Senzel, L.,
Gordon, M.,
Blaustein, R. O., Oh, K. J.,
Collier, R. J.,
and Finkelstein, A.
(2000)
J. Gen. Physiol.
115,
421-434 |
| 34. | Ren, J., Sharpe, J. C., Collier, R. J., and London, E. (1999) Biochemistry 38, 976-984[CrossRef][Medline] [Order article via Infotrieve] |
| 35. | Choe, S., Bennett, M. J., Fujii, G., Curmi, P. M., Kantardjieff, K. A., Collier, R. J., and Eisenberg, D. (1992) Nature 357, 216-222[CrossRef][Medline] [Order article via Infotrieve] |
| 36. | Bennett, M. J., and Eisenberg, D. (1994) Protein Sci. 3, 1464-1475[Abstract] |
| 37. | Parker, M. W., and Pattus, F. (1993) Trends Biochem. Sci. 18, 391-395[CrossRef][Medline] [Order article via Infotrieve] |
| 38. | Muchmore, S. W., Sattler, M., Liang, H., Meadows, R. P., Harlan, J. E., Yoon, H. S., Nettesheim, D., Chang, B. S., Thompson, C. B., Wong, S. L., Ng, S. L., and Fesik, S. W. (1996) Nature 381, 335-341[CrossRef][Medline] [Order article via Infotrieve] |
| 39. |
Nizard, P.,
Chenal, A.,
Beaumelle, B.,
Fourcade, A.,
and Gillet, D.
(2001)
Protein Eng.
14,
439-446 |
| 40. |
Chenal, A.,
Nizard, P.,
Forge, V.,
Pugniere, M.,
Roy, M. O.,
Mani, J. C.,
Guillain, F.,
and Gillet, D.
(2002)
Protein Eng.
15,
383-391 |
| 41. | Rigaud, J. L., Bluzat, A., and Buschlen, S. (1983) Biochem. Biophys. Res. Commun. 111, 373-382[CrossRef][Medline] [Order article via Infotrieve] |
| 42. | Nizard, P., Liger, D., Gaillard, C., and Gillet, D. (1998) FEBS Lett. 433, 83-88[CrossRef][Medline] [Order article via Infotrieve] |
| 43. |
Dumoulin, M.,
Conrath, K.,
Van Meirhaeghe, A.,
Meersman, F.,
Heremans, K.,
Frenken, L. G.,
Muyldermans, S.,
Wyns, L.,
and Matagne, A.
(2002)
Protein Sci
11,
500-515 |
| 44. | Kuwajima, K. (1996) FASEB J. 10, 102-109[Abstract] |
| 45. | Zhan, H., Oh, K. J., Shin, Y. K., Hubbell, W. L., and Collier, R. J. (1995) Biochemistry 34, 4856-4863[CrossRef][Medline] [Order article via Infotrieve] |
| 46. | Schulman, B. A., Kim, P. S., Dobson, C. M., and Redfield, C. (1997) Nat. Struct. Biol. 4, 630-634[CrossRef][Medline] [Order article via Infotrieve] |
| 47. | Balbach, J., Forge, V., van Nuland, N. A., Winder, S. L., Hore, P. J., and Dobson, C. M. (1995) Nat. Struct. Biol. 2, 865-870[CrossRef][Medline] [Order article via Infotrieve] |
| 48. | Forge, V., Wijesinha, R. T., Balbach, J., Brew, K., Robinson, C. V., Redfield, C., and Dobson, C. M. (1999) J. Mol. Biol. 288, 673-688[CrossRef][Medline] [Order article via Infotrieve] |
| 49. | Arai, M., and Kuwajima, K. (2000) Adv. Protein Chem. 53, 209-282[Medline] [Order article via Infotrieve] |
| 50. | Kuwajima, K., Mitani, M., and Sugai, S. (1989) J. Mol. Biol. 206, 547-561[CrossRef][Medline] [Order article via Infotrieve] |
| 51. |
Jamin, M.,
Geierstanger, B.,
and Baldwin, R. L.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
6127-6131 |
| 52. |
Guillain, F.,
Gingold, M. P.,
Buschlen, S.,
and Champeil, P.
(1980)
J. Biol. Chem.
255,
2072-2076 |
| 53. | Forge, V., Mintz, E., and Guillain, F. (1993) J. Biol. Chem. 268, 10961-10968 |